MiMedx Group, Inc. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
MiMedx Group, Inc. (MDXG) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2017-02-22.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2017-02-22
- MiMedx Group, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2015 was $0.00.
- MiMedx Group, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2014 was $0.00.
- MiMedx Group, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2013 was -$37.00K.
- MiMedx Group, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2012 was $0.00.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2017-02-22 |
| 2014-12-31 | $0.00 10-K · filed 2017-02-22 |
| 2013-12-31 | -$37.00K 10-K · filed 2017-02-22 |
| 2012-12-31 | $0.00 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |